Corporate governance is how MEGA protects trust. As a healthcare and wellness company operating across many markets, we believe that business growth must be built on integrity, transparency, accountability, compliance and responsible decision-making.

MEGA conducts business with high professional standards and no compromise on ethics. Our governance approach is guided by the values of Truth, Trust, Respect and Freedom, and supported by the Board of Directors, Board Committees, management responsibilities, internal controls, risk management, compliance processes, business ethics and clear policies.

Good governance allows us to protect shareholders’ rights, manage risks, uphold ethical conduct, strengthen responsible business practices, and build a company that can live and grow beyond all of us.

Corporate Governance at a Glance

MEGA’s corporate governance is supported by Board oversight, independent committees, policy frameworks, risk management, internal controls, compliance monitoring and transparent reporting.

  • Board of Directors
11directors
  • Independent Directors
5directors
  • Non-Executive Directors
4directors
  • Executive Directors
2directors
  • Female Directors
2directors
  • Board nationalities
More than 3nationalities
  • Board meetings in 2025
8meetings
  • Audit Committee
3
Independent Directors
  • Nomination Committee
100%
Independent Directors
  • Sustainability, Risk Management and Corporate Governance Committee
2meetings,
100%attendance
  • Anti-corruption training in 2025
Approximately
200hours
  • Whistleblowing cases confirmed with Audit Committee
1case, closed

Challenges and Opportunities

Corporate governance expectations continue to rise.

Stakeholders expect companies to show not only policies, but also clear oversight, responsible conduct, Board effectiveness, ethical business practices, anti-corruption controls, risk management, transparent reporting and mechanisms to raise concerns.

For MEGA, the challenge is to maintain strong governance across a business that operates in many markets and engages with employees, suppliers, customers, healthcare professionals, regulators, investors and communities. Different regulations, operating environments, business relationships and emerging risks require governance that is practical, consistent and continuously reviewed.

The opportunity is to make governance a source of resilience. When decision-making is transparent, risks are identified early, policies are communicated, concerns can be raised safely, and accountability is clear, MEGA can protect stakeholder trust and support long-term value creation.

Ethical and anti-corruption risks can arise across markets and business relationships.

Strengthen Anti-Bribery Policy, corruption risk assessment, training, CAC certification, whistleblowing and non-retaliation mechanisms.

ESG, climate, cyber, data privacy and operational risks are increasingly connected.

Link Board oversight, risk management, internal controls, business continuity and cyber security governance.

Investors and regulators expect accountable Board composition and performance.

Disclose Board independence, gender composition, skills, committee roles, self-assessment and succession planning.

Employees and affected persons need safe channels to raise concerns.

Maintain reporting channels, investigation procedures, Audit Committee reporting and non-retaliation protection.

Why Corporate Governance Matters to MEGA

MEGA’s business is connected to human health. This makes governance more than a compliance requirement. It is part of how we protect product quality, stakeholder trust, ethical conduct, business continuity and long-term growth.

Strong governance helps MEGA make better decisions in a changing operating environment. It supports the Board and management in overseeing strategy, risk, sustainability, compliance, internal control, anti-corruption, customer responsibility, supplier conduct, information security and responsible operations.

Corporate governance also supports the way we work with stakeholders. Shareholders need transparent information and fair treatment. Employees need clear expectations and safe reporting channels. Customers and healthcare professionals need responsible product information and ethical business conduct. Suppliers need fair and responsible business relationships. Communities and regulators need confidence that MEGA operates with integrity.

Our Corporate Governance Approach

MEGA’s corporate governance approach is built on Board oversight, management accountability, clear policies, internal controls, risk management, compliance monitoring and transparent communication.

The Board of Directors is responsible for strategy and oversight of the Company’s performance. Board members bring diverse skills and experience across areas such as pharmaceuticals, advertising, marketing, shipping and logistics, cyber-security and sales software, investment advisory, finance, consumer health and banking. This combination of experience helps MEGA oversee business performance and sustainability in a complex operating environment.

The Board is supported by committees with defined charters and responsibilities. Each committee plays a role in strengthening governance, internal control, audit, nomination, remuneration, sustainability, risk management and corporate governance.

Moreover, MEGA also uses a policy suite to guide conduct across the Company. The Business Ethics and Code of Conduct serves as the foundation document for MEGA’s policies and helps align governance, strategy and operations with integrity, compliance and responsible business conduct.

Board Oversight and Governance Structure

The Board of Directors plays a central role in MEGA’s governance and strategy. The Board oversees the Company’s performance, reviews policies, contributes to policy development, undertakes self-evaluation and supports the long-term direction of the business.

MEGA has a well-defined Authorization Table that lays down authority limits for the Board of Directors, Executives and Senior / Middle Management. The Company follows a detailed process for approvals from the Board of Directors and for sharing significant events.

The Board meets regularly. In 2025, the Board of Directors held 8 meetings. The Audit Committee meets at least four times a year, while other committees meet at least twice a year. Committee charters define roles and responsibilities so that each committee can support the Board in its area of oversight.

No. Name - Surname Board of Directors Position Audit Committee Position Nomination Committee Remuneration Committee Sustainability. RM & CG committee
1. Mr. Mechai Viravaidya 05/08 (63%)
2. Mr. Alan Kam 06/08 (75%) 03/04 (75%) 02/02 (100%)
3. Mr. Thor Santisiri 07/08 (88%) 04/04 (100%) 02/02 (100%)
4. Mr. Vijay Karwal 08/08 (100%) 04/04 (100%) 02/02 (100%)
5. Dr. Nithinart Sinthudeacha 08/08 (100%) 02/02 (100%) 02/02 (100%)
6. Mr. Kirit C. Shah 08/08 (100%) 02/02 (100%)
7. Mr. Ishaan Shah 07/08 (88%)
8. Ms. Sameera Shah 06/08 (75%)
9. Mr. Shiraz E. Poonevala 08/08 (75%)
10. Mr. Vivek Dhawan 08/08 (100%) 02/02 (100%) 02/02 (100%)
11 Mr. Thomas Abraham 08/08 (100%) 02/02 (100%)

Board Composition, Diversity and Skills

MEGA values a Board composition that supports effective oversight and long-term business strategy. In 2025, the Board of Directors comprised 11 directors, including 5 Independent Directors, 4 Non-Executive Directors and 2 Executive Directors. The Board included 2 female directors, one Independent Director and one Non-Executive Director, and comprised directors from more than three nationalities.

The Board brings together different experiences and perspectives. MEGA’s Board members have relevant experience in strategy, industry knowledge, accounting and finance, risk management, corporate governance and ESG. The Board also includes experience across pharmaceuticals, advertising, marketing, shipping and logistics, cyber-security and sales software, investment advisory, finance, consumer health and banking.

No. Name of Directors Strategy Industry Knowledge Accounting and Finance Risk Management Corporate Governance ESG
1. Mr. Mechai Viravaidya, Chairman and Independent Director
2. Mr. Alan Kam, Independent Director
3. Mr. Thor Santisiri, Independent Director
4. Mr. Vijay Karwal, Independent Director
5. Dr. Nithinart Sinthudeacha (Ms.) Independent Director
6. Mr. Kirit C. Shah, Non-executive Director
7. Mr. Ishaan Shah, Non-executive Director
8. Ms. Sameera Shah Non-executive Director
9. Mr. Vivek Dhawan, Executive Director
10. Mr. Thomas Abraham, Executive Director
11. Mr. Shiraz E. Poonevala, Non-executive Director

MEGA will continue to consider Board composition, diversity, skills and experience through the Nomination Committee and Board succession planning process. The Nomination Committee screens Board composition and encourages a strategically appropriate composition for the Company’s business and industry.

Board Composition

Board Category Male Female Total
Independent Directors 4 1 5
Non-Executive Directors 3 1 4
Executive Directors 2 0 2
Total 9 2 11

Board Committees and Responsibilities

MEGA’s Board Committees support the Board by reviewing matters in greater detail and providing recommendations within their areas of responsibility.

The Audit Committee is composed of three Independent Directors. The Committee is responsible for internal controls, appointment of external auditors, compliance, risk management and other controls necessary for the business. The Audit Committee also oversees internal and external audit matters and reviews observations and risks highlighted during audits.

The Nomination Committee is composed of Independent Directors. The Committee screens Board composition and encourages a strategically appropriate Board structure for MEGA’s business and industry. The Committee considers candidates from industry partners, professional search firms and diverse contacts, and ensures that roles are recommended for Board members based on their strengths and expertise. It also reviews Board and employee diversity, succession planning and training.

The Remuneration Committee benchmarks Board remuneration with available industry surveys, including IOD remuneration surveys, and reviews and approves management remuneration guidelines. Director remuneration is approved by shareholders at the Annual General Meeting.

The Sustainability, Risk Management and Corporate Governance Committee oversees sustainability in business practices, the risk management process and corporate governance practices. The Committee reviews sustainability initiatives, risk registers, policy implementation, corporate governance practices, business ethics, anti-bribery policy, director development and self-assessment.

Responsibility Area Audit Committee Nomination Committee Remuneration Committee Sustainability, Risk Management and Corporate Governance Committee
Internal control
External and internal audit
Board composition and diversity
Succession planning
Director and management remuneration
Sustainability oversight
Risk management oversight
Corporate governance policies
Business ethics and anti-bribery

Risk Management and Internal Controls

MEGA’s governance approach is connected to risk management and internal control. The Board of Directors and the Audit Committee oversee internal controls, while the Sustainability, Risk Management and Corporate Governance Committee reviews risk management and risk registers.

MEGA has a Risk Appetite Statement as a foundational document for risk management. The Company identifies key risks in consultation with locations where it operates, and each location head is considered a risk owner. The risk mitigation plan is followed up to ensure that risks are addressed and residual risks are managed as planned.

MEGA’s internal control framework is based on the Committee of Sponsoring Organizations (COSO). The Board of Directors and the Audit Committee oversee internal controls, and the Company outsources internal audits to third-party consulting companies.

The Company identifies climate change, data privacy, cyber preparedness and intellectual property as key emerging risks. This reinforces the need to connect governance with ESG, cyber security, business continuity and long-term resilience.

Shareholder Rights and Transparent Communication

MEGA respects shareholder rights and equitable treatment of shareholders. The Board of Directors and management consider it a priority to protect and uphold shareholder rights irrespective of the size of shareholding.

Shareholders have the right to participate in shareholder meetings, appoint proxies, vote for appointment or removal of individual directors, vote on appointment and remuneration of external auditors, vote on specific business matters, receive dividends and receive accurate and timely information.

MEGA also maintains an Investor Relations function to communicate and provide information about the Company’s data and operations to investors, shareholders, analysts and relevant agencies.

Board Evaluation, Succession and Development

MEGA arranges annual assessment and review of the Board of Directors and committees using the Stock Exchange of Thailand’s self-assessment guidelines. The assessment covers Board structure and characteristics, roles and responsibilities, Board meetings, Board performance, relationship with management, self-assessment of the Board, committees, individual directors and senior management, and self-development.

In 2025, the Board resolved to revise the performance assessment forms for the Board of Directors as recommended by the Corporate Governance and Sustainability Committee. The revision covered both collective performance and self-assessment forms and aimed to improve assessment effectiveness and alignment with current circumstances.

MEGA also maintains succession planning for directors and key executives. The Nomination Committee reviews succession plans for management and the Board of Directors, and the Board ensures systematic nomination of suitable candidates to replace directors or top executives when needed.

Director and management development also remains important. Board members, management and the Corporate Secretary have attended relevant director certification and governance-related programs, while MEGA continues to encourage directors and key executives to attend professional development programs.

Assessment Area Latest Disclosed Score
Score Percentage
Self Assessment of Board of Directors 3.78 94.5%
Self Assessment of Committee as a whole 3.80 95.0%
Self Assessment of Committee members on individual basis 3.91 97.7%
Questions with score less than 80% None

Remuneration Governance

MEGA’s Remuneration Committee reviews Board and management remuneration with reference to roles, responsibilities, Company performance and market benchmarking. The Committee benchmarks Board remuneration with available industry surveys, including IOD remuneration surveys.

Director remuneration is paid in quarterly installments and approved by shareholders at the Annual General Meeting. Executive Directors declined to accept remuneration as Directors.

The Remuneration Committee also reviews management compensation and guidelines for salary increments for key businesses. This helps ensure that remuneration is reviewed through a defined process and aligned with responsibilities and Company performance.

Disclosed Target / Management Focus

MEGA’s governance focus areas are connected to Board effectiveness, policy oversight, ethics, anti-corruption, risk management, internal controls, training and transparent reporting.

Board oversight

Continue Board oversight of strategy, performance, governance, risk management, internal control and sustainability.

Board composition

Continue reviewing Board structure, independence, diversity, skills, training and succession planning through the Nomination Committee.

Board evaluation

Continue annual Board and committee self-assessment and improve assessment forms and processes where appropriate.

Anti-corruption training

Target employees heading business dealings or interfacing with customers, government and regulatory agencies in 2026 and 2027.

Internal controls

Continue maintaining internal controls based on the COSO framework and using third-party internal audit support.

Responsible value chain

Continue supplier audits and governance expectations covering Good Manufacturing Practices, Human Rights and Employee Health and Safety.

Transparency

Continue public disclosure through the Sustainability Report, Form 56-1 One Report, governance dashboard and investor communication.

Whistleblowing Channel

Your questions and comments are important to us. Please use the form below to contact us and we will get back to you as soon as possible.